Myriad Signs Contract with UnitedHealthcare for MyRisk Hereditary Cancer Risk Panel | GenomeWeb

NEW YORK (GenomeWeb) – Myriad Genetics has signed a three-year contract with national payor UnitedHealthcare to provide access to its next-generation sequencing myRisk Hereditary Cancer test to beneficiaries who meet certain eligibility criteria for hereditary cancer risk.

The myRisk test gauges 25 genes associated with eight hereditary cancers, including breast, colon, ovarian, endometrial, pancreatic, prostate, and gastric cancers, and melanoma.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Startup companies are taking on personalized medicine, CNET reports.

Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.

The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.

In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.